Corporate
Outlook: No Trend
Action date: 07/22/2020
Rating action: Withdrawal
The credit rating has been withdrawn for economic reasons, axesor considers that the public need of maintaining the rating does not balance its expenses about update and monitoring.

GRIFOLS SA

The Spanish group Grifols is a benchmark company in blood products (a pharmaceutical specialty whose active ingredient originates from the blood of healthy donors) with a solid international track record. In 2018, the company's turnover reached € 4,487MM with an EBITDA of € 1,215MM (EBITDA Margin of 27%). NFD/EBITDA ratio stood at 4.3x.

Rating

Unsolicited
Date last rating: 07/25/2019
Date first rating: 07/26/2018